John Bridgewater

UCL Cancer Institute

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Gabriel Brooks

Associate Professor

UNITED STATES

View details

Darius Mirza

Professor of HPB Surgery and Transplantation

University Hospitals Birmingham NHS Foundation Trust

UNITED KINGDOM

View details

John Primrose

University of Southampton

UNITED KINGDOM

View details

Julien Edeline

PU-PH - Full Professor

Université de Rennes 1 Faculté de Médecine

FRANCE

View details

Juan W. Valle

The University of Manchester

UNITED KINGDOM

View details

Raj Prasad

Professor of Surgery, Section Chief of Liver Transplantation

Medical College of Wisconsin

UNITED STATES

View details

Joon Oh Park

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Pippa Corrie

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Christopher Jones

Clinical Lecturer

University of Cambridge

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Bridgewater

Research Interests

Explore related searches

Contact this professor

Articles (11)

Biological sex and chemotherapy treatment delays in patients with colorectal cancer

Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1–4 Inhibitor: Pooled Safety Analysis of 469 Patients

Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe

Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

Reply to J. Edeline et al

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study

Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”

Targeting FGFR inhibition in cholangiocarcinoma

Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position

Current standards and future perspectives in adjuvant treatment for biliary tract cancers

Collaborators (9)

Gabriel Brooks

Darius Mirza

John Primrose

Julien Edeline

Juan W. Valle

Raj Prasad

Joon Oh Park

Pippa Corrie

Christopher Jones

Make your next move.